Skip Navigation

Coronavirus (COVID-19) information for Dana-Farber patients & families Learn more

Hematology/Oncology Fellowships

  • Learn about the Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology.

  • Dana-Farber Cancer Institute, in collaboration with Mass General Brigham and Boston Children’s Hospital, offers two fellowship programs in hematology/oncology that provide clinical training and basic research training for MDs or MD/PhDs.

    • Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology
      • Hematology/Oncology Track
      • Classical Hematology Track
    • Pediatric Hematology/Oncology Training Program

    Dana-Farber/Mass General Brigham Fellowship in Adult Hematology/Oncology and Classical Hematology

    The Dana-Farber/Mass General Brigham Fellowship in Hematology/Oncology prepares academically oriented physicians to become leaders in clinical and laboratory investigation, clinical care, and education.

    The program has two interconnected tracks – a Hematology/Oncology Track that admits 14 new fellows each year, and a Classical Hematology Track that admits 2 new fellows each year. After an initial year of intensive clinical training, fellows in both tracks pursue two or more years of in-depth clinical, translational, and/or basic science research.

  • Clinical training in hematology/medical oncology

    During the first year of training, fellows in both the Hematology/Oncology Track and the Classical Hematology Track divide their time among the Dana-Farber, Massachusetts General Hospital (MGH), and Brigham and Women's Hospital (BWH) campuses. The combined institutions have more than 1,400 inpatient beds, and provide inpatient and ambulatory hematology and oncology care to patients from around the world.

    Hematology/Oncology Track: During the clinical year, outpatient hematology and oncology experiences are organized around disease-specific programs, and fellows are supervised directly by faculty mentors in each clinical division. Fellows working in inpatient services provide care and consultative services in hematology and medical oncology to a varied population of patients. Trainees also attend a wide variety of teaching conferences at both the Longwood (Dana-Farber and BWH) and MGH campuses. In addition, there are weekly disease-oriented teaching sessions sponsored by the relevant programs.

    Classical Hematology Track: The Classical Hematology track is a new addition to the Dana-Farber/Mass General Brigham Fellowship program. Interested applicants can begin submitting applications for the Classical Hematology Track in July 2022. The goal of the Classical Hematology Track is to prepare physicians for both clinical and research careers in classical hematology. During the clinical year, outpatient malignant and non-malignant hematology experiences will be organized around disease-specific programs, and fellows will be supervised directly by faculty mentors in each clinical division. Fellows working in inpatient services will provide care and consultative services in malignant and non-malignant hematology to a varied population of patients. Trainees will also attend a wide variety of teaching conferences at both the Longwood (Dana-Farber and BWH) and MGH campuses. Conferences will include joint conferences with the fellows in the Hematology/Oncology Track and conferences designed specifically for the Classical Hematology fellows.

  • Training beyond the first year

    In the second year and beyond, fellows in both the Hematology/Oncology Track and the Classical Hematology Track begin a period of immersive research, with the aim of assuming independent research programs in respected academic institutions.

    A variety of investigative opportunities, ranging from the most fundamental molecular biology to clinical trials and health outcome analyses, are available at Dana-Farber, Brigham and Women's Hospital, and MGH, as well as in laboratories located at the MGH Cancer Center in Charlestown, the Harvard Medical School, Boston Children's Hospital, and the Broad Institute of MIT and Harvard. Additional clinical training is available for those in the Hematology/Oncology Track desiring to board in hematology. Additionally, upper-level fellows maintain a longitudinal continuity clinic in the disease center and campus of their choosing.

  • Current Fellows

    Daniel Ardeljan, MD, PhD

    Daniel Ardeljan is originally from New York City. Daniel obtained his BS in Cell & Molecular Biology at Duke University and a combined MD/PhD from The Johns Hopkins University School of Medicine. He completed his residency in the Osler Medical Training Program at the Johns Hopkins Hospital. Prior to medical school, he served as a post-baccalaureate intramural research training associate at the National Institutes of Health studying age-related eye disease. He then attended the Johns Hopkins University Medical Scientist Training Program ... Read Daniel's full profile.

    Narsis Attar, MD, PhD

    Narsis Attar was born in Iran and grew up in California. Narsis earned her bachelor’s degree in Molecular and Cell Biology from University of California, Berkeley. She obtained her MD/PhD through the Medical Scientist Training Program at the University of California Los Angeles and completed her residency in Internal Medicine at the Massachusetts General Hospital. Prior to medical school, Narsis conducted basic and translational research studying immunotherapy and targeted therapy in metastatic melanoma at UCLA. She completed her PhD studies in Molecular Biology at UCLA ... Read Narsis's full profile.

    Mary Boulanger, MD

    Mary Boulanger grew up in Lexington, KY. She earned a BS in Human Nutrition and MD at the University of Kentucky. She then completed her internal medicine residency at Johns Hopkins. During her residency, Mary conducted clinical research in thoracic oncology focused on survivorship care and palliative care. ... Read Mary's full profile.

    Jamie O. Brett, MD, PhD

    Jamie Brett grew up in the Bay Area of Northern CA. Jamie went to Stanford for her undergraduate degree, where she worked on neural stem cell aging. She remained at Stanford for her MD and PhD degrees, investigating skeletal muscle stem cell quiescence, aging, and rejuvenation by exercise. Jamie then came to MGH for her Internal Medicine residency, where she researched resistance mechanisms and later-line therapies for hormone receptor-positive breast cancer. ... Read Jamie's full profile.

    Allison E.B. Chang, MD, PhD

    Allison Chang is originally from Farmington, CT. She attended Dartmouth College, where she studied neuroscience and chemistry. Allison then pursued a PhD in neurobiology at Harvard, where she studied the cellular and synaptic mechanisms by which neurons derive meaning from auditory and mechanosensory stimuli. After completing her PhD, Allison earned an MD at Harvard Medical School. Her residency training was at Brigham and Women’s Hospital ... Read Allison's full profile.

    Matthew J. Emmett, MD, PhD

    Matthew Emmett is originally from Philadelphia, PA. He obtained a BA in Biology and MS in Molecular and Cellular Biology at Johns Hopkins University, and an MD and PhD at the University of Pennsylvania. Matthew completed his doctoral dissertation studying the epigenomic and transcriptional regulation of metabolism. Following medical school, he completed his residency in Internal Medicine at the Massachusetts General Hospital, where he conducted clinical research in GI oncology ... Read Matthew's full profile.

    Emma C. Fink, MD, PhD

    Emma Fink is originally from Ontario, NY. She attended Amherst College, where she double majored in Biology and Chemistry. She then came to the Harvard-MIT MD/PhD program, where she completed her MD in the HST program and PhD in the BBS program. Emma continued her clinical training at Brigham and Women’s Hospital, where she completed her residency in Internal Medicine ... Read Emma's full profile.

    Benson M. George, MD, PhD

    Benson George is originally from East Meadow, NY. He obtained a BS in Biology at MIT, obtained an MD and PhD from Stanford University, and completed his residency in Internal Medicine at Brigham and Women’s Hospital. His thesis work investigated immunotherapeutic approaches for conditioning prior to hematopoietic stem cell transplant ... Read Benson's full profile.

    Eran Hodis, MD, PhD

    Eran Hodis is originally from Framingham, MA. He earned a BA in mathematics and biochemistry/molecular biology at Boston University, an MSc in bioinformatics from the Weizmann Institute of Science in Rehovot, Israel, a PhD in biophysics from Harvard University, and an MD from the HST program at Harvard Medical School and MIT. Eran completed residency in Internal Medicine at Brigham and Women’s Hospital ... Read Eran's full profile.

    Sara J. Khosrowjerdi, MD

    Sara Khosrowjerdi is originally from Wilbraham, MA (home of Friendly’s Ice Cream). She graduated summa cum laude from Tufts University, obtaining a BS in Biochemistry and BA in English. She earned her MD from Tufts University School of Medicine and completed her residency in Internal Medicine at Massachusetts General Hospital. Prior to medical school, she conducted research at Tufts University, synthesizing cyclic peptides to probe protein-protein interactions in the EGFR signaling pathway ... Read Sara's full profile.

    Lauren Merz, MSc, MD

    Lauren Merz is originally from Michigan. She obtained a BA in Kinesiology and Spanish from Calvin College, where she played varsity soccer and studied abroad in Spain, Mexico, and Honduras. She then obtained an MD from the University of Michigan Medical School and an MSc in Clinical Research from the University of Michigan School of Public Health before completing an Internal Medicine residency at Brigham and Women’s Hospital. While in medical school, she led the University of Michigan Student-Run Free Clinic ... Read Lauren's full profile.

    Ian A. Roundtree, MD, PhD

    Ian Roundtree is originally from Dunstable, MA. He obtained his undergraduate degree in Chemistry at Boston College, where he conducted research in synthetic organic chemistry. He then moved to Chicago, where he joined the Medical Scientist Training Program at the University of Chicago (PhD 2017, MD 2020). His doctoral research involved elucidating the role of reversible RNA modification in regulating gene expression. He completed his residency in Internal Medicine at the Massachusetts General Hospital as part of the Stanbury Physician Scientist Program ... Read Ian's full profile.

    Elliot C. Woods, MD, PhD

    Elliot Woods was born in Minneapolis, MN, but spent the latter half of his formative years in the Southeastern U.S. He received his bachelor’s degree in Chemical Engineering with a focus in biochemistry from the University of Pennsylvania. Elliot began his MD training at Emory University in Atlanta, but ended up at UC/Berkeley for a PhD in Bioengineering, working to characterize the role of glycans in oncogenesis. He completed his residency in Internal Medicine at Massachusetts General Hospital ... Read Elliot's full profile.

  • Past Fellows

    Second Year Fellows 2021

    Jordan M. Chinai, MD, PhD, Fellow DFCI/MGB
    Charles S. Dai, MD, Fellow DFCI/MGB
    Elijah P.B. Darnell, MD, Fellow DFCI/MGB
    Haley Ellis, MD, Fellow DFCI/MGB
    Dan Y. Gui, MD, PhD, Fellow DFCI/MGB
    Alexander C. Jordan, MD, Fellow DFCI/MGB
    Mwanasha H. Merrill, MD, Fellow DFCI/MGB
    Abirami Natarajan, MD, Fellow DFCI/MGB
    Rachel H. Occhiogrosso, MD, Fellow DFCI/MGB
    Leon Pappas, MSc, MD, PhD, Fellow DFCI/MGB
    Nolan Priedigkeit, MD, PhD, Fellow DFCI/MGB
    John C. Schell, MD, PhD, Fellow DFCI/MGB
    Vinayak Venkataraman, MD, Fellow DFCI/MGB
    Jeremiah Wala, MS, MD, PhD, Fellow DFCI/MGB

    Third Year Fellows 2020

    Justin S. Becker, MD, PhD, Fellow DFCI/MGB
    Elliott J. Brea, MD, PhD, Fellow DFCI/MGB
    Elizabeth J. Carstens, MD, Fellow DFCI/MGB
    Jooho Chung, MD, PhD, Fellow DFCI/MGB
    Alissa J. Cooper, MD, Fellow DFCI/MGB
    Brandon M. Huffman, MD, Fellow DFCI/MGB
    Nathalie R. Javidi-Sharifi MD, PhD, Fellow DFCI/MGB
    Janice S. Kim, MD, Fellow DFCI/MGB
    Marla D. Lipsyc-Sharf, MD, Fellow DFCI/MGB
    Asaf Maoz, MD, Fellow DFCI/MGB
    Richard A. Newcomb, MD, Fellow DFCI/MGB
    Erica M. Pimenta, MD, PhD, Fellow DFCI/MGB
    Thomas J. Roberts, MD, MBA, Fellow DFCI/MGB
    Christine E. Ryan, MD, Fellow DFCI/MGB
    Maclean S. Sellers, MD, PhD, Fellow DFCI/MGB
    Rebecca L. Zon, MD, Fellow DFCI/MGB

    2019

    Evan C. Chen, MD, Medical Oncologist at Dana Farber Cancer Institute
    William J. Gibson, MD, PhD, Fellow DFCI/MGB
    Julie E. Haydu, MD, PhD, Medical Oncologist at Massachusetts General Hospital
    Daniel E. Lage, MD, MBA, MSc, Medical Oncologist at Massachusetts General Hospital
    Jaclyn LoPiccolo, MD, PhD, Fellow DFCI/MGB
    Alexandra K. Maurer, MD, PhD, Medical Oncologist at Dana Farber Cancer Institute
    Catherine B. Meador, M, PhD, Medical Oncologist at Massachusetts General Hospital
    Arielle J. Medford, MD, Fellow DFCI/MGB
    Arnav Mehta, MD, PhD, Medical Oncologist at Massachusetts General Hospital
    Vivek Naranbhai, MBCHB, PhD, DPhil, Fellow DFCI/MGB
    Philipp J. Rauch, MD, Medical Oncologist at Dana Farber Cancer Institute
    Aswin Sekar, MD, PhD, Fellow DFCI/MGB
    Eleni Stavrou, MD, Memorial Sloan Kettering Cancer Center
    Matthew R. Strickland, MD, Medical Oncologist at Massachusetts General Hospital

    2018

    Steven M. Blum, MD, Medical Oncologist at Dana-Farber Cancer Institute
    Cynthia K. Hahn, MD, PhD, Fellow DF/MGB
    Chi-Joan How, MD, Medical Oncologist at Dana-Farber Cancer Institute
    P. Connor Johnson, MD, Instructor in Medicine at Massachusetts General Hospital
    Jonathan M.L. Ostrem, MD, PhD, Assistant Professor UCSF
    Jeffrey W. Patterson-Fortin, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Rishi Puram, MD, PhD, Fellow DF/MGB
    Praful K. Ravi, MBBCh, Medical Oncologist at Dana-Farber Cancer Institute
    Jaime L. Schneider, MD, PhD, Medical Oncologist at Massachusetts General Hospital
    Frederick D. Tsai, MD, PhD, Fellow DF/MGB
    Vivek Upadhyay, MD, Fellow DF/MGB
    Lachelle D. Weeks, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Kipp A. Weiskopf, MD, PhD, Fellow DF/MGB
    Jordan C. Wengrod, MD, PhD, Fellow DF/MGB

    2017

    Daniel L. Abravanel, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Sylvan C. Baca, MD, PhD, Medical Oncologist at Dana-Farber Cancer Institute
    Jacob E. Berchuck, MD, Medical Oncologist at Dana-Farber Cancer Institute
    Christopher T. Chen, MD, Medical Oncologist at Dana-Farber Cancer Institute
    Bradley D. Hunter, MD, MPH, Hematology/Oncology Intermountain Medical Group
    Geon Kim, MD, Hematology Attending Massachusetts General Hospital
    Erik K. Knelson, MD, PhD, Clinical Director, Early State Oncology, Merck
    Elizabeth K. Lee, MD, Medical Oncologist at Dana-Farber Cancer Institute
    Mark B. Leick, MD, Medical Oncologist at Massachusetts General Hospital
    Christopher S. Nabel, MD, PhD, Medical Oncologist at Massachusetts General Hospital
    Alexander A. Parent, MD, PhD, Medical Director, Oncology TAU, at Takeda Pharmaceuticals
    Christopher R. Reilly, MD, Medical Oncologist at Dana-Farber Cancer Institute
    James A. Torchia, MD, PhD, Fellow DF/MGB
    Mounica Vallurupalli, MD, Fellow DF/MGB

  • Application procedure

    All applications for this program are processed through the Electronic Residency Application Service (ERAS). Please note that both tracks are listed under Brigham and Women's Hospital, not Dana-Farber Cancer Institute. Applicants can apply to either one or both tracks.

    The deadline for applications is August 31.

    Contact us

    Kim Bremner
    Fellowship Coordinator
    Phone: 617-632-3474
    Fax: 617-632-2260
    Email: kim_bremner@dfci.harvard.edu 

  • Pediatric Hematology/Oncology Fellowship Program

    The Pediatric Hematology/Oncology Fellowship Program at Dana-Farber Cancer Institute and Boston Children's Hospital is one of the oldest and most distinguished in the world.

    The program admits six new fellows per year. Fellows spend one year in full-time clinical work and two or more years in research training, depending on previous training and interests.

    The program is geared to broadly train MD or MD/PhD fellows in any of the areas of clinical research, including outcomes, ethics, epidemiology, therapeutic trials, and translational research, or in one of the major basic science disciplines: protein chemistry, structural biology, molecular biology, stem cell and developmental biology, genetics, genomics, immunology, systems biology, neuroscience, or cell biology.

    The breadth and diversity of our patient population, combined with the depth of expertise of our teaching faculty, provides the highest quality clinical training in pediatric hematology and oncology. Our program also offers unparalleled opportunities for research and scholarship, fostering the academic passions of all fellows.

    Learn more about the Pediatric Hematology/Oncology Fellowship Program.